Test Price
2,800 AED✅ Home Collection Available
FGFR3 Gene Crouzon Syndrome with Acanthosis Nigricans Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FGFR3 لمتلازمة كروزون مع الشواك الأسود في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Next‑Generation Sequencing (NGS), certified under ISO 9001:2015.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM–11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation with our DHA‑licensed clinical geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology Comparison
The FGFR3 Genetic Test identifies pathogenic variants in the FGFR3 gene associated with Crouzon syndrome with acanthosis nigricans, enabling definitive molecular diagnosis and informed clinical management. يوفر هذا التحليل الجيني تشخيصاً دقيقاً لمتلازمة كروزون المصحوبة بالشواك الأسود عبر تقنية حديثة فائقة الحساسية.
| Feature | Our NGS Test (ISO 9001:2015) | Standard Sanger Sequencing |
|---|---|---|
| Precision (Sensitivity) | 99.9% – covers entire coding region, deletions/duplications | ~95% – limited to single amplicons, miss larger CNVs |
| Methodology | Next‑Generation Sequencing (NGS) + bio‑informatics | Capillary electrophoresis, single‑gene sequencing |
| Turnaround Time | 3–4 Weeks (express possible) | 4–6 Weeks |
| Regulatory Compliance | DHA‑MOHAP NGS Standards, ISO 9001:2015, UAE PDPL | May lack ISO accreditation |
Physician Insight & Safety Protocol
“As a clinical geneticist, I emphasize that every FGFR3 variant must be interpreted in the full clinical picture. This NGS test provides high‑resolution data, yet a negative result does not exclude all craniosynostosis syndromes; correlation with physical findings, imaging, and family history is essential. Please discuss all results with your geneticist before making any medical decisions.”
– Dr. Prabhakar Reddy, DHA License 61713011
⚠ Medication & Clinical Safety Notice
Do not discontinue prescribed medication or hormonal therapy without consulting your personal doctor. Genetic test results alone do not override existing treatment plans.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals under 18 years without legal guardian consent; patients unable to provide a sufficient blood/DNA sample; those with active systemic infection at collection site that cannot be rescheduled.
- Exclusion: Prior allogeneic bone marrow transplantation may interfere with genetic analysis of blood DNA – a pre‑test buccal swab or fibroblast culture may be advised.
- ER Red Flags: If the patient (especially an infant) develops sudden intense headaches, projectile vomiting, downward gaze deviation (sunset sign), or rapid head enlargement, seek immediate emergency care – these can indicate raised intracranial pressure due to craniosynostosis.
Frequently Asked Questions (Pre‑ & Post‑Test)
1. What does the FGFR3 NGS test detect in Crouzon syndrome with acanthosis nigricans?
Direct Answer (Snippet Optimized): The FGFR3 NGS test identifies pathogenic DNA variants in the entire FGFR3 gene, confirming the specific mutation causing Crouzon syndrome with acanthosis nigricans.
الإجابة المباشرة: يكشف اختبار FGFR3 بتقنية التسلسل الجيني عن الطفرات المرضية في جين FGFR3 المسؤولة عن ظهور متلازمة كروزون مع الشواك الأسود.
2. How should I prepare before giving blood for this genetic?
Direct Answer (Snippet Optimized): No fasting or medication adjustments are required; simply hydrate well and provide your detailed personal/family medical history for accurate variant interpretation.
الإجابة المباشرة: لا يشترط الصيام أو تعديل الأدوية، فقط احرص على شرب الماء وتجهيز تاريخ طبي دقيق لك ولعائلتك لضمان تفسير دقيق للنتيجة.
3. My child’s result shows a “variant of uncertain significance” – what now?
Direct Answer (Snippet Optimized): A variant of uncertain significance requires clinical correlation and possibly testing of both parents to clarify whether it is disease‑causing or benign.
الإجابة المباشرة: في حال ظهور طفرة غير محددة الأهمية، يجب ربطها بالفحص السريري وفحص الوالدين جينياً لتحديد مدى تسببها بالمرض.
ISO 9001:2015 Certified: Certificate INT/EGQ/2509DA/3139. All testing complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL (Data Privacy).
DHA Facility License: 9834453 | Support: +971545488731 (WhatsApp, 8 AM–11 PM)
Medical Disclaimer: This page is for educational purposes and does not replace professional medical advice. Always seek the guidance of a DHA‑licensed physician.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians